83 related articles for article (PubMed ID: 6572563)
1. Clinical correlations of leukemic clonogenic cell chemosensitivity assessed by in vitro continuous exposure to drugs.
Park CH; Wiernik PH; Morrison FS; Amare M; Van Sloten KV; Maloney TR
Cancer Res; 1983 May; 43(5):2346-9. PubMed ID: 6572563
[TBL] [Abstract][Full Text] [Related]
2. Chemotherapy sensitivity assessment of leukemic colony-forming cells with in vitro simultaneous exposure to multiple drugs: clinical correlations in acute nonlymphocytic leukemia.
Park CH; Amare M; Morrison FS; Maloney TR; Goodwin JW
Cancer Treat Rep; 1982 Jun; 66(6):1257-61. PubMed ID: 7083232
[TBL] [Abstract][Full Text] [Related]
3. Prediction of response to chemotherapy in acute leukemia by in vitro drug sensitivity testing on leukemic stem cells.
Gustavsson A; Olofsson T
Cancer Res; 1984 Oct; 44(10):4648-52. PubMed ID: 6590116
[TBL] [Abstract][Full Text] [Related]
4. Impact of in vivo administration of interleukin 3 on proliferation, differentiation, and chemosensitivity of acute myeloid leukemia.
Gore SD; Weng LJ; Jones RJ; Cowan K; Zilcha M; Piantadosi S; Burke PJ
Clin Cancer Res; 1995 Mar; 1(3):295-303. PubMed ID: 9815985
[TBL] [Abstract][Full Text] [Related]
5. [An in vitro chemotherapy sensitivity test on leukemic colony-forming cells (L-CFU) and its clinical evaluation].
Moriyama Y; Urushiyama M; Hirosawa H; Koyama S; Takai K; Fujiwara M; Kishi K; Takahashi M; Sakai C; Sanada M; Shibata A
Gan To Kagaku Ryoho; 1982 Oct; 9(10):1749-54. PubMed ID: 7184371
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of high-dose 1-beta-D-arabinofuranosylcytosine for acute leukemia and refractory lymphoma: clinical response and pharmacology.
Early AP; Preisler HD; Slocum H; Rustum YM
Cancer Res; 1982 Apr; 42(4):1587-94. PubMed ID: 6949642
[TBL] [Abstract][Full Text] [Related]
7. Relationship of the growth of leukemic cells in vitro to the outcome of therapy for acute nonlymphocytic leukemia.
Preisler HD; Azarnia N; Marinello M
Cancer Res; 1984 Apr; 44(4):1712-7. PubMed ID: 6704977
[TBL] [Abstract][Full Text] [Related]
8. Thymidine as a kinetic and biochemical modulator of 1-beta-D-arabinofuranosylcytosine in human acute nonlymphocytic leukemia.
Blumenreich MS; Chou TC; Andreeff M; Vale K; Clarkson BD; Young CW
Cancer Res; 1984 Feb; 44(2):825-30. PubMed ID: 6692380
[TBL] [Abstract][Full Text] [Related]
9. Short course infusional idarubicin plus intermittent cytarabine and etoposide for refractory hematologic malignancies: clinical and preliminary pharmacological results.
Bassan R; Chiodini B; Zucchetti M; Lerede T; Cornelli PE; Cortelazzo S; Barbui T
Haematologica; 1998 Jan; 83(1):27-33. PubMed ID: 9542320
[TBL] [Abstract][Full Text] [Related]
10. Effects on leukemic clonogenic cells in murine myeloid leukemia of 1-beta-D-arabinofuranosylcytosine and the anthracyclines adriamycin, daunomycin, aclacinomycin A, and 4'-epidoxorubicin.
Nara N; Yamashita Y; Murohashi I; Tanikawa S; Imai Y; Aoki N
Cancer Res; 1987 May; 47(9):2376-9. PubMed ID: 3471325
[TBL] [Abstract][Full Text] [Related]
11. Anthracyclines in the treatment of acute nonlymphocytic leukemias.
Boiron M; Jacquillat C; Marty M; Weil M; Gisselbrecht C
Cancer Treat Rep; 1981; 65 Suppl 4():73-6. PubMed ID: 6955013
[No Abstract] [Full Text] [Related]
12. Cytotoxic effects of 1-beta-D-arabinofuranosylcytosine and 6-thioguanine in vitro on granulocytic progenitor cells.
Greenberg PL; VanKersen I; Mosny S
Cancer Res; 1976 Dec; 36(12):4412-7. PubMed ID: 1069606
[TBL] [Abstract][Full Text] [Related]
13. In vitro short-term sensitivity test for the prediction of response to chemotherapy in acute non-lymphocytic leukemia.
Saccardi R; Bernabei PA; Bezzini R; Agostino FC; Leoni F; Rossi Ferrini P
Chemioterapia; 1988 Jun; 7(3):173-8. PubMed ID: 3168072
[TBL] [Abstract][Full Text] [Related]
14. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
[TBL] [Abstract][Full Text] [Related]
15. Studies with anthracyclines in pediatric acute nonlymphocytic leukemia.
Chard RL
Cancer Treat Rep; 1981; 65 Suppl 4():77-81. PubMed ID: 6179617
[TBL] [Abstract][Full Text] [Related]
16. Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-D-arabinofuranosylcytosine in patients with refractory acute leukemia.
Cragg LH; Andreeff M; Feldman E; Roberts J; Murgo A; Winning M; Tombes MB; Roboz G; Kramer L; Grant S
Clin Cancer Res; 2002 Jul; 8(7):2123-33. PubMed ID: 12114412
[TBL] [Abstract][Full Text] [Related]
17. Normalization of in vitro sensitivity testing of human tumor clonogenic cells.
Hug V; Thames H; Blumenschein GR; Spitzer G; Drewinko B
Cancer Res; 1984 Mar; 44(3):923-8. PubMed ID: 6692414
[TBL] [Abstract][Full Text] [Related]
18. Drug sensitivity test for acute myeloblastic leukemia by an efficient leukemic blast colony assay using 5637-conditioned medium as a stimulator.
Asano Y; Okamura S; Shibuya T; Morioka E; Harada M; Akazawa K; Niho Y
J Med; 1990; 21(6):289-99. PubMed ID: 2093096
[TBL] [Abstract][Full Text] [Related]
19. In vitro sensitivity of leukemic clonogenic cells to four anthracyclines (adriamycin, daunorubicin, rubidazone and aclacinomycin) in human acute myeloid leukemia.
Marie JP; Thevenin D; Zittoun R
Nouv Rev Fr Hematol (1978); 1985; 27(3):163-7. PubMed ID: 3862071
[TBL] [Abstract][Full Text] [Related]
20. Radiation sensitivity of leukemic progenitor cells in acute nonlymphocytic leukemia.
Ozawa K; Miura Y; Suda T; Motoyoshi K; Takaku F
Cancer Res; 1983 May; 43(5):2339-41. PubMed ID: 6339049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
